MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma
Head and Neck Cancer
Melanoma
Bladder Urothelial Carcinoma

Interventions

GENETIC: Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells

Sponsor

Adaptimmune